nodes	percent_of_prediction	percent_of_DWPC	metapath
Zopiclone—PTGS1—Montelukast—chronic obstructive pulmonary disease	0.113	0.187	CbGbCtD
Zopiclone—CYP2E1—Aminophylline—chronic obstructive pulmonary disease	0.0981	0.162	CbGbCtD
Zopiclone—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0654	0.108	CbGbCtD
Zopiclone—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0601	0.0992	CbGbCtD
Zopiclone—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0601	0.0992	CbGbCtD
Zopiclone—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0461	0.0761	CbGbCtD
Zopiclone—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0456	0.0752	CbGbCtD
Zopiclone—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0312	0.0514	CbGbCtD
Zopiclone—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0297	0.049	CbGbCtD
Zopiclone—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0265	0.0437	CbGbCtD
Zopiclone—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0156	0.0256	CbGbCtD
Zopiclone—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0147	0.0242	CbGbCtD
Zopiclone—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000369	0.00121	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000368	0.00121	CcSEcCtD
Zopiclone—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000365	0.0012	CcSEcCtD
Zopiclone—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000365	0.0012	CcSEcCtD
Zopiclone—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000364	0.0012	CcSEcCtD
Zopiclone—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000364	0.00119	CcSEcCtD
Zopiclone—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000364	0.00119	CcSEcCtD
Zopiclone—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000363	0.00119	CcSEcCtD
Zopiclone—Mood swings—Prednisolone—chronic obstructive pulmonary disease	0.000359	0.00118	CcSEcCtD
Zopiclone—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000359	0.00118	CcSEcCtD
Zopiclone—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000359	0.00118	CcSEcCtD
Zopiclone—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000359	0.00118	CcSEcCtD
Zopiclone—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000359	0.00118	CcSEcCtD
Zopiclone—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000359	0.00118	CcSEcCtD
Zopiclone—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000359	0.00118	CcSEcCtD
Zopiclone—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000357	0.00117	CcSEcCtD
Zopiclone—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000357	0.00117	CcSEcCtD
Zopiclone—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000357	0.00117	CcSEcCtD
Zopiclone—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000357	0.00117	CcSEcCtD
Zopiclone—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000357	0.00117	CcSEcCtD
Zopiclone—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000357	0.00117	CcSEcCtD
Zopiclone—Neuropathy—Prednisone—chronic obstructive pulmonary disease	0.000356	0.00117	CcSEcCtD
Zopiclone—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000354	0.00116	CcSEcCtD
Zopiclone—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000354	0.00116	CcSEcCtD
Zopiclone—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000351	0.00115	CcSEcCtD
Zopiclone—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000351	0.00115	CcSEcCtD
Zopiclone—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000351	0.00115	CcSEcCtD
Zopiclone—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000351	0.00115	CcSEcCtD
Zopiclone—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00035	0.00115	CcSEcCtD
Zopiclone—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000348	0.00114	CcSEcCtD
Zopiclone—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.000347	0.00114	CcSEcCtD
Zopiclone—GABRG3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000347	0.0039	CbGpPWpGaD
Zopiclone—CYP2C9—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000345	0.00387	CbGpPWpGaD
Zopiclone—GABRA3—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000344	0.00387	CbGpPWpGaD
Zopiclone—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000344	0.00113	CcSEcCtD
Zopiclone—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000344	0.00113	CcSEcCtD
Zopiclone—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000343	0.00113	CcSEcCtD
Zopiclone—Infection—Formoterol—chronic obstructive pulmonary disease	0.000341	0.00112	CcSEcCtD
Zopiclone—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000341	0.00112	CcSEcCtD
Zopiclone—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000339	0.00381	CbGpPWpGaD
Zopiclone—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000339	0.00111	CcSEcCtD
Zopiclone—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000339	0.00111	CcSEcCtD
Zopiclone—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000338	0.00111	CcSEcCtD
Zopiclone—GABRA2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000338	0.0038	CbGpPWpGaD
Zopiclone—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000337	0.00111	CcSEcCtD
Zopiclone—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000337	0.00111	CcSEcCtD
Zopiclone—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000337	0.00111	CcSEcCtD
Zopiclone—GABRB3—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000336	0.00377	CbGpPWpGaD
Zopiclone—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000335	0.0011	CcSEcCtD
Zopiclone—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000335	0.0011	CcSEcCtD
Zopiclone—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000334	0.0011	CcSEcCtD
Zopiclone—Infection—Montelukast—chronic obstructive pulmonary disease	0.000334	0.0011	CcSEcCtD
Zopiclone—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000334	0.0011	CcSEcCtD
Zopiclone—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000333	0.00109	CcSEcCtD
Zopiclone—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000331	0.00109	CcSEcCtD
Zopiclone—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00033	0.00371	CbGpPWpGaD
Zopiclone—GABRG2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00033	0.00371	CbGpPWpGaD
Zopiclone—PTGS1—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000328	0.00368	CbGpPWpGaD
Zopiclone—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000326	0.00107	CcSEcCtD
Zopiclone—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000325	0.00366	CbGpPWpGaD
Zopiclone—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000325	0.00107	CcSEcCtD
Zopiclone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000323	0.00363	CbGpPWpGaD
Zopiclone—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000322	0.00106	CcSEcCtD
Zopiclone—GABRB2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000321	0.00361	CbGpPWpGaD
Zopiclone—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000319	0.00105	CcSEcCtD
Zopiclone—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000318	0.00104	CcSEcCtD
Zopiclone—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000317	0.00104	CcSEcCtD
Zopiclone—PTGS1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000316	0.00355	CbGpPWpGaD
Zopiclone—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000314	0.00103	CcSEcCtD
Zopiclone—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000314	0.00103	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000313	0.00103	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000313	0.00103	CcSEcCtD
Zopiclone—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000313	0.00352	CbGpPWpGaD
Zopiclone—GABRA5—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000312	0.00351	CbGpPWpGaD
Zopiclone—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000311	0.00102	CcSEcCtD
Zopiclone—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000311	0.00102	CcSEcCtD
Zopiclone—GABRB2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000311	0.00349	CbGpPWpGaD
Zopiclone—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000309	0.00102	CcSEcCtD
Zopiclone—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000309	0.00101	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000307	0.00101	CcSEcCtD
Zopiclone—GABRA3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000307	0.00345	CbGpPWpGaD
Zopiclone—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000306	0.00101	CcSEcCtD
Zopiclone—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000306	0.00101	CcSEcCtD
Zopiclone—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000306	0.001	CcSEcCtD
Zopiclone—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000306	0.001	CcSEcCtD
Zopiclone—GABRA1—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000305	0.00342	CbGpPWpGaD
Zopiclone—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000304	0.001	CcSEcCtD
Zopiclone—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000303	0.000993	CcSEcCtD
Zopiclone—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000303	0.000993	CcSEcCtD
Zopiclone—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000302	0.000993	CcSEcCtD
Zopiclone—GABRA5—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000302	0.00339	CbGpPWpGaD
Zopiclone—GABRA2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000301	0.00339	CbGpPWpGaD
Zopiclone—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000301	0.000989	CcSEcCtD
Zopiclone—Injury—Prednisone—chronic obstructive pulmonary disease	0.000299	0.000983	CcSEcCtD
Zopiclone—GABRB3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000299	0.00336	CbGpPWpGaD
Zopiclone—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000299	0.000983	CcSEcCtD
Zopiclone—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000299	0.00098	CcSEcCtD
Zopiclone—CYP2E1—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000298	0.00335	CbGpPWpGaD
Zopiclone—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000298	0.000978	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000297	0.000974	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000297	0.000974	CcSEcCtD
Zopiclone—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000296	0.000973	CcSEcCtD
Zopiclone—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000296	0.000973	CcSEcCtD
Zopiclone—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000296	0.000973	CcSEcCtD
Zopiclone—GABRA3—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000296	0.00333	CbGpPWpGaD
Zopiclone—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000296	0.000971	CcSEcCtD
Zopiclone—GABRG2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000294	0.0033	CbGpPWpGaD
Zopiclone—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000294	0.000965	CcSEcCtD
Zopiclone—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000294	0.000965	CcSEcCtD
Zopiclone—Pain—Formoterol—chronic obstructive pulmonary disease	0.000294	0.000965	CcSEcCtD
Zopiclone—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000294	0.000965	CcSEcCtD
Zopiclone—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000294	0.000964	CcSEcCtD
Zopiclone—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000293	0.000962	CcSEcCtD
Zopiclone—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000293	0.000962	CcSEcCtD
Zopiclone—GABRB2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000292	0.00328	CbGpPWpGaD
Zopiclone—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000291	0.000957	CcSEcCtD
Zopiclone—CYP2C8—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000291	0.00327	CbGpPWpGaD
Zopiclone—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000291	0.00327	CbGpPWpGaD
Zopiclone—GABRA2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000291	0.00327	CbGpPWpGaD
Zopiclone—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000291	0.000954	CcSEcCtD
Zopiclone—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00029	0.000953	CcSEcCtD
Zopiclone—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000289	0.00095	CcSEcCtD
Zopiclone—GABRB3—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000289	0.00325	CbGpPWpGaD
Zopiclone—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000289	0.000947	CcSEcCtD
Zopiclone—GABRA1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000288	0.00324	CbGpPWpGaD
Zopiclone—Pain—Montelukast—chronic obstructive pulmonary disease	0.000288	0.000945	CcSEcCtD
Zopiclone—CYP2E1—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000287	0.00323	CbGpPWpGaD
Zopiclone—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000287	0.000943	CcSEcCtD
Zopiclone—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000286	0.000939	CcSEcCtD
Zopiclone—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000286	0.000938	CcSEcCtD
Zopiclone—PTGS1—Overview of nanoparticle effects—TNF—chronic obstructive pulmonary disease	0.000285	0.00321	CbGpPWpGaD
Zopiclone—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000285	0.000935	CcSEcCtD
Zopiclone—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000284	0.000934	CcSEcCtD
Zopiclone—GABRG2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000284	0.00319	CbGpPWpGaD
Zopiclone—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000284	0.000931	CcSEcCtD
Zopiclone—GABRA5—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000284	0.00319	CbGpPWpGaD
Zopiclone—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000283	0.00093	CcSEcCtD
Zopiclone—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000283	0.00093	CcSEcCtD
Zopiclone—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000283	0.000929	CcSEcCtD
Zopiclone—GABRG3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000283	0.00318	CbGpPWpGaD
Zopiclone—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000283	0.00318	CbGpPWpGaD
Zopiclone—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000282	0.000926	CcSEcCtD
Zopiclone—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000282	0.000925	CcSEcCtD
Zopiclone—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000281	0.000923	CcSEcCtD
Zopiclone—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000281	0.000923	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00028	0.00092	CcSEcCtD
Zopiclone—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00028	0.000919	CcSEcCtD
Zopiclone—GABRA3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000279	0.00313	CbGpPWpGaD
Zopiclone—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000278	0.000911	CcSEcCtD
Zopiclone—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000278	0.000911	CcSEcCtD
Zopiclone—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000275	0.000904	CcSEcCtD
Zopiclone—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000275	0.000904	CcSEcCtD
Zopiclone—GABRA2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000274	0.00308	CbGpPWpGaD
Zopiclone—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000273	0.000896	CcSEcCtD
Zopiclone—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000273	0.000896	CcSEcCtD
Zopiclone—GABRB3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000272	0.00306	CbGpPWpGaD
Zopiclone—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000272	0.000892	CcSEcCtD
Zopiclone—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000272	0.000892	CcSEcCtD
Zopiclone—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000272	0.000892	CcSEcCtD
Zopiclone—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000272	0.000892	CcSEcCtD
Zopiclone—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000271	0.00305	CbGpPWpGaD
Zopiclone—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000271	0.000889	CcSEcCtD
Zopiclone—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000271	0.000889	CcSEcCtD
Zopiclone—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000269	0.000882	CcSEcCtD
Zopiclone—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000268	0.000881	CcSEcCtD
Zopiclone—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000268	0.000881	CcSEcCtD
Zopiclone—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000267	0.000878	CcSEcCtD
Zopiclone—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000267	0.000878	CcSEcCtD
Zopiclone—GABRG2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000267	0.003	CbGpPWpGaD
Zopiclone—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000267	0.000876	CcSEcCtD
Zopiclone—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000266	0.000874	CcSEcCtD
Zopiclone—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000266	0.000874	CcSEcCtD
Zopiclone—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000266	0.000872	CcSEcCtD
Zopiclone—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000265	0.000871	CcSEcCtD
Zopiclone—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000263	0.000862	CcSEcCtD
Zopiclone—CYP2E1—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000262	0.00294	CbGpPWpGaD
Zopiclone—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000261	0.000856	CcSEcCtD
Zopiclone—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000258	0.000846	CcSEcCtD
Zopiclone—CYP2C8—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000257	0.00289	CbGpPWpGaD
Zopiclone—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000257	0.00289	CbGpPWpGaD
Zopiclone—GABRA1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000257	0.00289	CbGpPWpGaD
Zopiclone—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000257	0.000842	CcSEcCtD
Zopiclone—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000257	0.000842	CcSEcCtD
Zopiclone—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000253	0.000831	CcSEcCtD
Zopiclone—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000253	0.000831	CcSEcCtD
Zopiclone—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000253	0.000831	CcSEcCtD
Zopiclone—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000252	0.000828	CcSEcCtD
Zopiclone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000252	0.00283	CbGpPWpGaD
Zopiclone—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.00025	0.000822	CcSEcCtD
Zopiclone—GABRA1—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000249	0.0028	CbGpPWpGaD
Zopiclone—CYP2C8—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000248	0.00279	CbGpPWpGaD
Zopiclone—GABRA1—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000248	0.00279	CbGpPWpGaD
Zopiclone—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000248	0.000814	CcSEcCtD
Zopiclone—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000247	0.00081	CcSEcCtD
Zopiclone—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000247	0.00081	CcSEcCtD
Zopiclone—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000243	0.000798	CcSEcCtD
Zopiclone—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000243	0.000798	CcSEcCtD
Zopiclone—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000243	0.000797	CcSEcCtD
Zopiclone—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000242	0.000793	CcSEcCtD
Zopiclone—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000239	0.000785	CcSEcCtD
Zopiclone—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000238	0.000782	CcSEcCtD
Zopiclone—GABRB2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000238	0.00267	CbGpPWpGaD
Zopiclone—CYP2C9—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000237	0.00266	CbGpPWpGaD
Zopiclone—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000236	0.00266	CbGpPWpGaD
Zopiclone—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000236	0.00265	CbGpPWpGaD
Zopiclone—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000235	0.000772	CcSEcCtD
Zopiclone—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000235	0.000772	CcSEcCtD
Zopiclone—GABRA1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000233	0.00262	CbGpPWpGaD
Zopiclone—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000233	0.000764	CcSEcCtD
Zopiclone—GABRA5—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000231	0.0026	CbGpPWpGaD
Zopiclone—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00023	0.000756	CcSEcCtD
Zopiclone—PTGS1—Overview of nanoparticle effects—IL6—chronic obstructive pulmonary disease	0.00023	0.00259	CbGpPWpGaD
Zopiclone—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00023	0.000754	CcSEcCtD
Zopiclone—PTGS1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.00023	0.00258	CbGpPWpGaD
Zopiclone—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000227	0.00255	CbGpPWpGaD
Zopiclone—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000227	0.000746	CcSEcCtD
Zopiclone—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000227	0.000746	CcSEcCtD
Zopiclone—GABRA3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000227	0.00255	CbGpPWpGaD
Zopiclone—GABRA1—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000225	0.00253	CbGpPWpGaD
Zopiclone—GABRA2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000223	0.00251	CbGpPWpGaD
Zopiclone—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000223	0.000731	CcSEcCtD
Zopiclone—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000222	0.000729	CcSEcCtD
Zopiclone—GABRB3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000222	0.00249	CbGpPWpGaD
Zopiclone—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000219	0.000719	CcSEcCtD
Zopiclone—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000219	0.000717	CcSEcCtD
Zopiclone—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000219	0.000717	CcSEcCtD
Zopiclone—GABRG2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000218	0.00245	CbGpPWpGaD
Zopiclone—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000217	0.000712	CcSEcCtD
Zopiclone—Rash—Formoterol—chronic obstructive pulmonary disease	0.000217	0.000712	CcSEcCtD
Zopiclone—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000217	0.000711	CcSEcCtD
Zopiclone—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000217	0.000711	CcSEcCtD
Zopiclone—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000216	0.000711	CcSEcCtD
Zopiclone—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000215	0.000707	CcSEcCtD
Zopiclone—Headache—Formoterol—chronic obstructive pulmonary disease	0.000215	0.000707	CcSEcCtD
Zopiclone—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000215	0.000707	CcSEcCtD
Zopiclone—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000215	0.000706	CcSEcCtD
Zopiclone—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000215	0.000705	CcSEcCtD
Zopiclone—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000214	0.000703	CcSEcCtD
Zopiclone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000213	0.00239	CbGpPWpGaD
Zopiclone—Rash—Montelukast—chronic obstructive pulmonary disease	0.000212	0.000697	CcSEcCtD
Zopiclone—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000212	0.000696	CcSEcCtD
Zopiclone—CYP2C8—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000212	0.00238	CbGpPWpGaD
Zopiclone—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000212	0.00238	CbGpPWpGaD
Zopiclone—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000212	0.000695	CcSEcCtD
Zopiclone—Depression—Prednisone—chronic obstructive pulmonary disease	0.000211	0.000694	CcSEcCtD
Zopiclone—Headache—Montelukast—chronic obstructive pulmonary disease	0.000211	0.000692	CcSEcCtD
Zopiclone—CYP2C9—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00021	0.00235	CbGpPWpGaD
Zopiclone—CYP2E1—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000209	0.00235	CbGpPWpGaD
Zopiclone—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000208	0.000684	CcSEcCtD
Zopiclone—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000208	0.000683	CcSEcCtD
Zopiclone—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000206	0.000677	CcSEcCtD
Zopiclone—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000206	0.000675	CcSEcCtD
Zopiclone—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000205	0.000673	CcSEcCtD
Zopiclone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000205	0.0023	CbGpPWpGaD
Zopiclone—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000205	0.000672	CcSEcCtD
Zopiclone—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000204	0.000671	CcSEcCtD
Zopiclone—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000204	0.00067	CcSEcCtD
Zopiclone—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000204	0.00067	CcSEcCtD
Zopiclone—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000204	0.00229	CbGpPWpGaD
Zopiclone—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000203	0.000668	CcSEcCtD
Zopiclone—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000202	0.00227	CbGpPWpGaD
Zopiclone—PTGS1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000202	0.00227	CbGpPWpGaD
Zopiclone—Nausea—Montelukast—chronic obstructive pulmonary disease	0.0002	0.000657	CcSEcCtD
Zopiclone—PTGS1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.0002	0.00224	CbGpPWpGaD
Zopiclone—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000198	0.000649	CcSEcCtD
Zopiclone—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000197	0.000647	CcSEcCtD
Zopiclone—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000193	0.000633	CcSEcCtD
Zopiclone—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000192	0.00063	CcSEcCtD
Zopiclone—GABRA1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00019	0.00214	CbGpPWpGaD
Zopiclone—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000189	0.000622	CcSEcCtD
Zopiclone—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000186	0.000611	CcSEcCtD
Zopiclone—PTGS1—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.000185	0.00208	CbGpPWpGaD
Zopiclone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000183	0.00206	CbGpPWpGaD
Zopiclone—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000182	0.000596	CcSEcCtD
Zopiclone—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000181	0.00203	CbGpPWpGaD
Zopiclone—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.00018	0.000591	CcSEcCtD
Zopiclone—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000172	0.00194	CbGpPWpGaD
Zopiclone—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000172	0.00193	CbGpPWpGaD
Zopiclone—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000168	0.000553	CcSEcCtD
Zopiclone—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000168	0.000552	CcSEcCtD
Zopiclone—PTGS1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000168	0.00189	CbGpPWpGaD
Zopiclone—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000167	0.000549	CcSEcCtD
Zopiclone—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000167	0.00188	CbGpPWpGaD
Zopiclone—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000166	0.00187	CbGpPWpGaD
Zopiclone—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000159	0.000523	CcSEcCtD
Zopiclone—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000156	0.000513	CcSEcCtD
Zopiclone—GABRA1—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000156	0.00175	CbGpPWpGaD
Zopiclone—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000154	0.000505	CcSEcCtD
Zopiclone—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000153	0.000504	CcSEcCtD
Zopiclone—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000153	0.000503	CcSEcCtD
Zopiclone—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000152	0.0005	CcSEcCtD
Zopiclone—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000151	0.000497	CcSEcCtD
Zopiclone—CYP2E1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000151	0.0017	CbGpPWpGaD
Zopiclone—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000149	0.000491	CcSEcCtD
Zopiclone—CYP2E1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000149	0.00168	CbGpPWpGaD
Zopiclone—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000149	0.000489	CcSEcCtD
Zopiclone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000149	0.00167	CbGpPWpGaD
Zopiclone—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000148	0.00167	CbGpPWpGaD
Zopiclone—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000148	0.000486	CcSEcCtD
Zopiclone—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000147	0.00165	CbGpPWpGaD
Zopiclone—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000144	0.000471	CcSEcCtD
Zopiclone—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000143	0.00047	CcSEcCtD
Zopiclone—PTGS1—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	0.000142	0.0016	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000142	0.00159	CbGpPWpGaD
Zopiclone—PTGS1—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	0.000142	0.00159	CbGpPWpGaD
Zopiclone—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000463	CcSEcCtD
Zopiclone—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000462	CcSEcCtD
Zopiclone—PTGS1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.00014	0.00157	CbGpPWpGaD
Zopiclone—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000139	0.000458	CcSEcCtD
Zopiclone—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000138	0.00155	CbGpPWpGaD
Zopiclone—GABRA1—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000138	0.00155	CbGpPWpGaD
Zopiclone—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000137	0.00045	CcSEcCtD
Zopiclone—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000135	0.000444	CcSEcCtD
Zopiclone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000135	0.00152	CbGpPWpGaD
Zopiclone—Infection—Prednisone—chronic obstructive pulmonary disease	0.000134	0.000441	CcSEcCtD
Zopiclone—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000133	0.0015	CbGpPWpGaD
Zopiclone—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000132	0.000433	CcSEcCtD
Zopiclone—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000131	0.000429	CcSEcCtD
Zopiclone—CYP2C8—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.00013	0.00147	CbGpPWpGaD
Zopiclone—CYP2C8—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000129	0.00145	CbGpPWpGaD
Zopiclone—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000129	0.000423	CcSEcCtD
Zopiclone—PTGS1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000129	0.00145	CbGpPWpGaD
Zopiclone—CYP2E1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000125	0.00141	CbGpPWpGaD
Zopiclone—CYP2E1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000124	0.00139	CbGpPWpGaD
Zopiclone—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000123	0.000405	CcSEcCtD
Zopiclone—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000123	0.000404	CcSEcCtD
Zopiclone—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000402	CcSEcCtD
Zopiclone—PTGS1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000122	0.00137	CbGpPWpGaD
Zopiclone—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000399	CcSEcCtD
Zopiclone—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000121	0.00136	CbGpPWpGaD
Zopiclone—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000121	0.00136	CbGpPWpGaD
Zopiclone—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000119	0.000391	CcSEcCtD
Zopiclone—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000118	0.000386	CcSEcCtD
Zopiclone—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000117	0.000385	CcSEcCtD
Zopiclone—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000117	0.000385	CcSEcCtD
Zopiclone—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000117	0.000383	CcSEcCtD
Zopiclone—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000117	0.000383	CcSEcCtD
Zopiclone—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000116	0.00038	CcSEcCtD
Zopiclone—PTGS1—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	0.000115	0.0013	CbGpPWpGaD
Zopiclone—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000366	CcSEcCtD
Zopiclone—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000363	CcSEcCtD
Zopiclone—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000111	0.000363	CcSEcCtD
Zopiclone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.00011	0.00123	CbGpPWpGaD
Zopiclone—CYP2C8—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000108	0.00122	CbGpPWpGaD
Zopiclone—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000107	0.000353	CcSEcCtD
Zopiclone—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000107	0.000351	CcSEcCtD
Zopiclone—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000107	0.000351	CcSEcCtD
Zopiclone—CYP2C8—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000107	0.0012	CbGpPWpGaD
Zopiclone—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000106	0.00119	CbGpPWpGaD
Zopiclone—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000105	0.00118	CbGpPWpGaD
Zopiclone—CYP2E1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000105	0.00118	CbGpPWpGaD
Zopiclone—CYP2E1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000103	0.00116	CbGpPWpGaD
Zopiclone—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	9.97e-05	0.000327	CcSEcCtD
Zopiclone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	9.82e-05	0.0011	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—APIP—chronic obstructive pulmonary disease	9.81e-05	0.0011	CbGpPWpGaD
Zopiclone—Asthenia—Prednisone—chronic obstructive pulmonary disease	9.7e-05	0.000319	CcSEcCtD
Zopiclone—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	9.69e-05	0.00109	CbGpPWpGaD
Zopiclone—CYP2E1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	9.61e-05	0.00108	CbGpPWpGaD
Zopiclone—Pruritus—Prednisone—chronic obstructive pulmonary disease	9.57e-05	0.000314	CcSEcCtD
Zopiclone—CYP2E1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	9.48e-05	0.00107	CbGpPWpGaD
Zopiclone—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	9.25e-05	0.000304	CcSEcCtD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	9.17e-05	0.00103	CbGpPWpGaD
Zopiclone—CYP2E1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	9.11e-05	0.00102	CbGpPWpGaD
Zopiclone—CYP2C8—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	9.04e-05	0.00102	CbGpPWpGaD
Zopiclone—CYP2E1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	8.99e-05	0.00101	CbGpPWpGaD
Zopiclone—Dizziness—Prednisone—chronic obstructive pulmonary disease	8.94e-05	0.000294	CcSEcCtD
Zopiclone—CYP2C8—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	8.92e-05	0.001	CbGpPWpGaD
Zopiclone—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	8.82e-05	0.000991	CbGpPWpGaD
Zopiclone—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	8.7e-05	0.000978	CbGpPWpGaD
Zopiclone—Vomiting—Prednisone—chronic obstructive pulmonary disease	8.6e-05	0.000282	CcSEcCtD
Zopiclone—GABRA1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	8.53e-05	0.000959	CbGpPWpGaD
Zopiclone—Rash—Prednisone—chronic obstructive pulmonary disease	8.53e-05	0.00028	CcSEcCtD
Zopiclone—Dermatitis—Prednisone—chronic obstructive pulmonary disease	8.52e-05	0.00028	CcSEcCtD
Zopiclone—Headache—Prednisone—chronic obstructive pulmonary disease	8.47e-05	0.000278	CcSEcCtD
Zopiclone—GABRG3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	8.4e-05	0.000944	CbGpPWpGaD
Zopiclone—PTGS1—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	8.37e-05	0.00094	CbGpPWpGaD
Zopiclone—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	8.31e-05	0.000934	CbGpPWpGaD
Zopiclone—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	8.19e-05	0.000921	CbGpPWpGaD
Zopiclone—GABRA1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	8.18e-05	0.00092	CbGpPWpGaD
Zopiclone—Nausea—Prednisone—chronic obstructive pulmonary disease	8.03e-05	0.000264	CcSEcCtD
Zopiclone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	7.96e-05	0.000894	CbGpPWpGaD
Zopiclone—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7.88e-05	0.000885	CbGpPWpGaD
Zopiclone—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	7.77e-05	0.000873	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	7.46e-05	0.000838	CbGpPWpGaD
Zopiclone—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.36e-05	0.000827	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—APIP—chronic obstructive pulmonary disease	7.33e-05	0.000824	CbGpPWpGaD
Zopiclone—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.26e-05	0.000815	CbGpPWpGaD
Zopiclone—GABRB2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	7.07e-05	0.000795	CbGpPWpGaD
Zopiclone—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7e-05	0.000787	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	7e-05	0.000786	CbGpPWpGaD
Zopiclone—GABRA1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	6.93e-05	0.000779	CbGpPWpGaD
Zopiclone—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.92e-05	0.000778	CbGpPWpGaD
Zopiclone—GABRA5—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	6.87e-05	0.000772	CbGpPWpGaD
Zopiclone—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.76e-05	0.00076	CbGpPWpGaD
Zopiclone—PTGS1—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	6.75e-05	0.000759	CbGpPWpGaD
Zopiclone—GABRA3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	6.75e-05	0.000758	CbGpPWpGaD
Zopiclone—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.67e-05	0.000749	CbGpPWpGaD
Zopiclone—GABRA2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	6.63e-05	0.000745	CbGpPWpGaD
Zopiclone—GABRB3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	6.59e-05	0.00074	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.5e-05	0.00073	CbGpPWpGaD
Zopiclone—GABRG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	6.47e-05	0.000727	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	6.44e-05	0.000724	CbGpPWpGaD
Zopiclone—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.41e-05	0.00072	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	6.34e-05	0.000712	CbGpPWpGaD
Zopiclone—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.32e-05	0.00071	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—GC—chronic obstructive pulmonary disease	6.32e-05	0.00071	CbGpPWpGaD
Zopiclone—GABRA1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	5.94e-05	0.000667	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.88e-05	0.00066	CbGpPWpGaD
Zopiclone—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.82e-05	0.000654	CbGpPWpGaD
Zopiclone—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.74e-05	0.000645	CbGpPWpGaD
Zopiclone—GABRA1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	5.66e-05	0.000635	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	5.16e-05	0.000579	CbGpPWpGaD
Zopiclone—GABRG3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.05e-05	0.000567	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.86e-05	0.000546	CbGpPWpGaD
Zopiclone—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.85e-05	0.000545	CbGpPWpGaD
Zopiclone—GABRA1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	4.79e-05	0.000539	CbGpPWpGaD
Zopiclone—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.79e-05	0.000538	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—GC—chronic obstructive pulmonary disease	4.72e-05	0.000531	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.68e-05	0.000526	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.52e-05	0.000508	CbGpPWpGaD
Zopiclone—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.46e-05	0.000501	CbGpPWpGaD
Zopiclone—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.4e-05	0.000494	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.39e-05	0.000493	CbGpPWpGaD
Zopiclone—GABRB2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.25e-05	0.000477	CbGpPWpGaD
Zopiclone—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.23e-05	0.000475	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.2e-05	0.000472	CbGpPWpGaD
Zopiclone—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.17e-05	0.000469	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.16e-05	0.000468	CbGpPWpGaD
Zopiclone—GABRA5—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.13e-05	0.000464	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	4.08e-05	0.000459	CbGpPWpGaD
Zopiclone—GABRA3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.05e-05	0.000455	CbGpPWpGaD
Zopiclone—GABRA2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.98e-05	0.000447	CbGpPWpGaD
Zopiclone—GABRB3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.96e-05	0.000445	CbGpPWpGaD
Zopiclone—GABRG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.88e-05	0.000437	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.8e-05	0.000427	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.68e-05	0.000413	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.45e-05	0.000388	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.42e-05	0.000384	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—GCLC—chronic obstructive pulmonary disease	3.41e-05	0.000384	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	3.4e-05	0.000382	CbGpPWpGaD
Zopiclone—GABRA1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.4e-05	0.000382	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.39e-05	0.000381	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	3.32e-05	0.000373	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.18e-05	0.000358	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—CTGF—chronic obstructive pulmonary disease	3.12e-05	0.00035	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.09e-05	0.000347	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.02e-05	0.00034	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.87e-05	0.000322	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.58e-05	0.00029	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.55e-05	0.000287	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.46e-05	0.000277	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.39e-05	0.000269	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.36e-05	0.000265	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.33e-05	0.000262	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.25e-05	0.000253	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.23e-05	0.000251	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	2.21e-05	0.000248	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.2e-05	0.000247	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.19e-05	0.000246	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.14e-05	0.000241	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.09e-05	0.000234	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.06e-05	0.000231	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.04e-05	0.000229	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	2.01e-05	0.000226	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.85e-05	0.000208	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.82e-05	0.000204	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	1.79e-05	0.000202	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.79e-05	0.000201	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.76e-05	0.000198	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.67e-05	0.000188	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.64e-05	0.000185	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	1.64e-05	0.000184	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.56e-05	0.000175	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.55e-05	0.000174	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.52e-05	0.000171	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.51e-05	0.00017	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.42e-05	0.00016	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—ALB—chronic obstructive pulmonary disease	1.42e-05	0.000159	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.36e-05	0.000152	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.35e-05	0.000151	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.26e-05	0.000141	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.24e-05	0.000139	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.2e-05	0.000135	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.18e-05	0.000133	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.16e-05	0.00013	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.1e-05	0.000123	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.08e-05	0.000121	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	1.06e-05	0.000119	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.01e-05	0.000114	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.95e-06	0.000112	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	9.16e-06	0.000103	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	8.76e-06	9.84e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.3e-06	9.33e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.19e-06	9.2e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.63e-06	8.57e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	7.45e-06	8.37e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.23e-06	8.12e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	7.13e-06	8.01e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	4.91e-06	5.52e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	4.7e-06	5.28e-05	CbGpPWpGaD
